Odyssey Therapeutics, Inc. (ODTX)

Odyssey Therapeutics will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Odyssey Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Debt / Equity Ratio	-0.06	-0.06	-0.08
Debt / EBITDA Ratio	-0.27	-0.27	-0.43
Debt / FCF Ratio	-0.06	-0.06	-0.08
Net Debt / Equity Ratio	0.32	0.32	0.26
Net Debt / EBITDA Ratio	1.52	1.52	1.36
Net Debt / FCF Ratio	0.32	0.32	0.26
Quick Ratio	6.85	6.85	4.55
Return on Equity (ROE)	30.44%	30.44%	33.81%
Return on Assets (ROA)	-55.10%	-55.10%	-65.50%
Return on Capital Employed (ROCE)	-64.08%	-64.08%	-81.25%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).